Manisha Pai
Public Communications Contact at VERTEX PHARMACEUTICALS INCORPORATED
Manisha Pai active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Public Communications Contact | - | - |
Career history of Manisha Pai
Former positions of Manisha Pai
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Investor Relations Contact | 30/04/2015 | 30/09/2017 |
| Public Communications Contact | 30/04/2015 | 30/09/2017 | |
| EPIZYME, INC. | Investor Relations Contact | 30/04/2014 | 31/03/2015 |
| Public Communications Contact | 30/04/2014 | 31/03/2015 | |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 30/06/2013 | 31/12/2013 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31/07/2008 | 30/06/2013 |
| MAGENTA THERAPEUTICS | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Training of Manisha Pai
| Amherst College | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 4 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Manisha Pai
- Experience